A Study of JNJ-89402638 for Metastatic Colorectal Cancer
Phase 1
170
about 3.8 years
18+
5 sites in CO, FL, IN +2
About this study
This trial is testing a treatment called JNJ-89402638 in people with advanced colorectal cancer that cannot be surgically removed. The goal is to find the best dose of this medication and see if it's safe at that dose.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take JNJ-89402638
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
bevacizumab
infusion
Primary: Part 1 and Part 2: Number of Participants with Adverse Events (AEs) by Severity, Part 1: Number of Participants with Dose-Limiting Toxicity (DLT)
Secondary: Part 1 and Part 2: Area Under the Serum Concentration-time Curve (AUC) of JNJ-89402638, Part 1 and Part 2: Complete Response (CR), Part 1 and Part 2: Duration of Response (DOR), Part 1 and Part 2: Maximum Serum Concentration (Cmax) of JNJ-89402638, Part 1 and Part 2: Overall Response (OR), Part 1 and Part 2: Time to Reach Maximum Observed Serum Concentration (Tmax) of JNJ-89402638
Oncology